Select Drug Formulary - AmeriHealth
Low-to-moderate dose statin for prevention of cardiovascular disease, recommended for ages 40-75 years without a history of CVD when 1 or more CVD risk factors are present (e.g., dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year risk of a cardiovascular event of 10% or greater lovastatin 10mg lovastatin 20mg lovastatin 40mg
Download Select Drug Formulary - AmeriHealth
Information
Domain:
Source:
Link to this page:
Documents from same domain
ICD-10 Putting Codes Into Practice - AmeriHealth
www.amerihealth.comdesigned to communicate various coding conventions, general guidelines, and chapter-specific guidelines in ICD-10.
Authorization for Release of Information - AmeriHealth
www.amerihealth.comAuthorization to Release Information [Please Print] This form is used to release your protected health information as required by federal and state privacy laws. Your authorization allows the Health Plan (your health insurance carrier or HMO) to release your protected health information to a person or organization that you choose. ...
2017 – 2018 Clinical Practice Guidelines Summary
www.amerihealth.comAmeriHealth 2017 – 2018 Clinical Practice Guidelines Summary* Condition Evidence Reference URL Diabetes American Diabetes Association Standards of Medical Care in
UB-04 claim form and instructions - AmeriHealth
www.amerihealth.com12.09 1 The Office of Management and Budget and the National Uniform Billing Committee have approved the UB-04 claim form, also known as the CMS-1450 form.
Quality Management Program Goals and Objectives - PA
www.amerihealth.comObjectives The goals and objectives of the QM Program are: To improve the quality of medical and behavioral health care and service provided to Members through administrative simplification and a comprehensive and ongoing system of monitoring measurable performance indicators (including indicators based on high-volume, ...
Related documents
<insert self-management goal> Quick Reference Guide
guidelines.diabetes.caStatin (if CVD, age ≥40 for type 2, OR diabetes complications) ASA (if CVD) SGLT2i/GLP1ra with demonstrated CV benefi t (if have ... Statin1 1 Dose adjustments or additional lipid therapy warranted if lipid target (LDL-C <2.0 mmol/L) not being met. 2 ACE-inhibitor or ARB (angiotensin receptor blocker) should be given at doses that have ...
Major Recommendations for Statin Therapy for ...
www.mplsheart.comintensity statin if: LDL > 160 mg/dl, family history, hs CRP > 2, CAC>300 or 75%, ABI < .9, or high lifetime risk. Clinical atherosclerotic cardiovascular disease LDL-C ≥ 190 mg/dl Type 1 or 2 Diabetes age 40-75 Age 40-75 Estimated 10 yr atherosclerotic CVD risk > 7.5% High-Intensity Statin Daily dose lowers LDL-C by approx ≥ 50%
Table 5. Statin Dose Intensity and Equivalency Chart*
www.mqic.orgStatin Dose Intensity and Equivalency Chart* Statin Intensity %LDL-C Reduction HMG-CoA Reductase Inhibitor Rosuvastatin Atorvastatin Pitavastatin Simvastatin Lovastatin Pravastatin Fluvastatin High-Intensity (lowers LDL-C ≥ 50%) 63 40 mg ($196) 62 61 60 80mg ($9 gen, $ 236. br) 59 58 56 20 mg 54 ($196) 52
US-56427 ---------------------------- DOSAGE AND ...
den8dhaj6zs0e.cloudfront.netInitiate treatment with a 180 mg loading dose of BRILINTA then continue with 90 mg twice daily for up to 30 days. (2.3) Use BRILINTA with a daily maintenance dose of aspirin of …
Health Care Reform Preventive Services Coding Guide
www.bluecrossnc.com(Low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years.)
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euDose dependent increases in blood lipid parameters were reported in patients treated with baricitinib (see section 4.8). Elevations in low density lipoprotein (LDL) cholesterol decreased to pre-treatment levels in response to statin therapy. Lipid parameters should be assessed approximately 12 weeks
2021 HEDIS® Provider Pocket Guide COMMERCIAL/MEDICARE
www.healthnet.comStatin Therapy for Patients with Cardiovascular Disease (SPC) 84 Care Coordination Transitions of Care 95 Addendum ... the type/dose of medication, if needed. Outreach to patients at risk of noncompliance (missing at least 1 reill) via phone calls, medication prompts, or case management. 7 :